The time is ripe to study the pharmacy workforce, said David Mott, RPh, PhD, professor of social and administrative sciences at the UW–Madison School of Pharmacy.

Loren Bonner

A pharmacy may be held liable for malpractice if a pharmacist breaches a duty to warn a patient of potential medication risks.

David B. Brushwood, BSPharm, JD

The arrival of AI is no longer just somewhere out on the horizon. Generative AI—technology that creates new text, images, or code in response to human prompts—has become a lab tool, reshaping how student pharmacists study, learn to counsel, and prepare for clinical practice.

Sonya Collins

In the United States, where heart disease remains the leading cause of death and nearly half the population suffers from high BP, the challenge of controlling hypertension remains a top priority for health care providers.

Elizabeth Briand

It may sound like something out of a futuristic film: Researchers used an automated compounding platform based on 3D printing to create pediatric corticosteroid formulations.

Elizabeth Briand

Updates from FDA

APhA Staff

Approximately 16.5 million adults in the United States live with atopic dermatitis (a form of eczema), while dry skin (xerosis) affects approximately 20% of the population at any given time.

Mary Warner

Millions of Americans use kratom to treat chronic pain, fatigue, depression, or anxiety, despite limited clinical evidence supporting its use.

Mickie Cathers

According to the results of a NEJM study from May 2025, as-needed use of albuterol-budesonide resulted in a lower risk of severe asthma exacerbation than use of albuterol alone, specifically among patients with uncontrolled mild asthma despite treatment.

Lauren Howell, PharmD

In September 2025, HHS announced actions it would take—including a letter to physicians and the beginning stage of a process for a safety label change—to address the potential risk of autism associated with prenatal acetaminophen exposure.

Sonya Collins

Marina Maes, PharmD, acknowledges that her patients needing GLP-1 receptor agonists face obstacles such as shortages and the expense of injectables.

Jen Hand

Following completion of the VICTORIA trial, vericiguat was approved for the treatment of worsening heart failure with HFrEF.

APhA Staff

A review published in the August 2025 issue of the Australian Journal of General Practice cautions that small missteps in pain management for patients with advanced cancer can lead to large clinical consequences.

Aiya Almogaber, PharmD

Updated guidance from the American Thoracic Society (ATS), published online on July 17, 2025 in The American Journal of Respiratory and Critical Care Medicine, revises and reverses recommendations on antimicrobial and corticosteroid therapy for community-acquired pneumonia (CAP), a major cause of adult morbidity and mortality.

Corey Diamond, PharmD

A recent expert consensus statement from the American College of Cardiology (ACC) is reshaping how clinicians diagnose and manage pericarditis.

Aiya Almogaber, PharmD

A study published online on October 7, 2025, in BMJ Evidence-Based Medicine found that tramadol may have a slight effect on reducing chronic pain, but the potential harms seem to outweigh any benefit.

Kevin Willmann

This year has proven to be a tumultuous time for vaccine recommendations, and perhaps for the first time, national professional medical associations such as the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG), and the Infectious Disease Society of America (IDSA) have published guidelines that depart from those of ACIP and CDC.

Michelle D. Fiscus, MD, FAAP

APhA Member News

APhA staff

Take the Crossword Challenge